See more : Ipsos SA (IPS.PA) Income Statement Analysis – Financial Results
Complete financial analysis of MedTech Acquisition Corporation (MTAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MedTech Acquisition Corporation, a leading company in the Shell Companies industry within the Financial Services sector.
- Infomart Corporation (2492.T) Income Statement Analysis – Financial Results
- Kkrrafton Developers Limited (KDL.BO) Income Statement Analysis – Financial Results
- Raiffeisen Bank International AG (RAIFY) Income Statement Analysis – Financial Results
- American Environmental Energy, Inc. (AEEI) Income Statement Analysis – Financial Results
- Stampede Drilling Inc. (SDI.V) Income Statement Analysis – Financial Results
MedTech Acquisition Corporation (MTAC)
Industry: Shell Companies
Sector: Financial Services
About MedTech Acquisition Corporation
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 18.51M | 12.40M | 8.40M | 5.43M |
| Cost of Revenue | 2.61M | 2.26M | 1.19M | 2.20M |
| Gross Profit | 15.91M | 10.14M | 7.21M | 3.24M |
| Gross Profit Ratio | 85.93% | 81.79% | 85.80% | 59.55% |
| Research & Development | 29.51M | 21.36M | 14.22M | 15.83M |
| General & Administrative | 23.51M | 12.48M | 8.75M | 6.87M |
| Selling & Marketing | 17.03M | 12.74M | 8.26M | 6.19M |
| SG&A | 40.55M | 25.22M | 17.02M | 13.06M |
| Other Expenses | 0.00 | -8.73M | 746.00K | 0.00 |
| Operating Expenses | 70.06M | 46.58M | 31.24M | 29.02M |
| Cost & Expenses | 72.66M | 48.84M | 32.43M | 31.22M |
| Interest Income | 431.00K | 180.00K | 64.00K | 0.00 |
| Interest Expense | 16.00K | 1.00K | 1.76M | 0.00 |
| Depreciation & Amortization | 702.00K | 414.00K | 464.00K | 321.00K |
| EBITDA | -58.30M | -46.76M | -23.57M | -25.33M |
| EBITDA Ratio | -314.94% | -359.68% | -271.66% | -466.05% |
| Operating Income | -54.15M | -36.44M | -24.03M | -25.65M |
| Operating Income Ratio | -292.53% | -293.91% | -286.06% | -471.95% |
| Total Other Income/Expenses | -4.88M | -10.74M | -4.81M | -6.18M |
| Income Before Tax | -59.03M | -47.18M | -28.84M | -31.83M |
| Income Before Tax Ratio | -318.89% | -380.53% | -343.32% | -585.68% |
| Income Tax Expense | 9.00K | 9.00K | 3.00K | 4.00K |
| Net Income | -59.04M | -47.19M | -28.85M | -31.83M |
| Net Income Ratio | -318.93% | -380.60% | -343.35% | -585.76% |
| EPS | -6.73 | -1.59 | -0.92 | -1.04 |
| EPS Diluted | -6.73 | -1.59 | -0.92 | -1.04 |
| Weighted Avg Shares Out | 9.40M | 29.61M | 31.25M | 30.56M |
| Weighted Avg Shares Out (Dil) | 9.40M | 29.61M | 31.25M | 30.56M |
MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders
Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal
Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company
Source: https://incomestatements.info
Category: Stock Reports